Pharvaris Nv logo

Pharvaris Nv share price today

(PHVS)

Pharvaris Nv share price is $18.06 & ₹1,549.73 as on 7 Jan 2025, 2.30 'hrs' IST

$18.06

-0.47

(-2.54%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Pharvaris Nv share price in Dollar and Rupees. Guide to invest in Pharvaris Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pharvaris Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Pharvaris Nv share price movements

  • Today's Low: $18.05
    Today's High: $18.60

    Day's Volatility :2.96%

  • 52 Weeks Low: $15.37
    52 Weeks High: $33.00

    52 Weeks Volatility :53.42%

Pharvaris Nv Returns

PeriodPharvaris NvSector (Health Care)Index (Russel 2000)
3 Months
3.52%
-8.4%
0.0%
6 Months
6.8%
-3.8%
0.0%
1 Year
-28.76%
-0.1%
0.0%
3 Years
2.89%
2.9%
-19.8%

Pharvaris Nv Key Statistics

in dollars & INR

Previous Close
$18.53
Open
$18.3
Today's High
$18.6
Today's Low
$18.05
Market Capitalization
$1.0B
Today's Volume
$119.3K
52 Week High
$33.0
52 Week Low
$15.37
Revenue TTM
$0.0
EBITDA
$-116.1M
Earnings Per Share (EPS)
$-2.7
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-45.05%

How to invest in Pharvaris Nv from India?

It is very easy for Indian residents to invest directly in Pharvaris Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pharvaris Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pharvaris Nv or PHVS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pharvaris Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pharvaris Nv shares which would translate to 0.048 fractional shares of Pharvaris Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pharvaris Nv, in just a few clicks!

Returns in Pharvaris Nv for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pharvaris Nv investment value today

Current value as on today

₹72,657

Returns

₹27,343

(-27.34%)

Returns from Pharvaris Nv Stock

₹30,565 (-30.57%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Pharvaris Nv

-29%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Pharvaris Nv on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -29% less investors are searching Pharvaris Nv in the last 30 days versus the previous period.

Analyst Recommendation on Pharvaris Nv

Buy

    84%Buy

    7%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Pharvaris Nv(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
1
1
1

Analyst Forecast on Pharvaris Nv

What analysts predicted

Upside of 88.9%

Current:

$18.06

Target:

$34.12

Insights on Pharvaris Nv

  • Price Movement

    In the last 7 days, PHVS stock has moved down by -2.6%
  • PHVS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 49.6%
  • PHVS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 44.2%

Pharvaris Nv Technicals Summary

Sell

Neutral

Buy

Pharvaris Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Pharvaris Nv Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pharvaris Nv
-0.05%
6.8%
-28.76%
2.89%
-36.1%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pharvaris Nv
NA
NA
NA
-2.63
-0.45
-0.27
NA
7.35
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pharvaris Nv
Buy
$1.0B
-36.1%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Pharvaris Nv

pharvaris is a preclinical stage company focused on bringing an oral bradykinin b2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (hae) and other b2 receptor-mediated indications. the company reunites the core team responsible for the discovery and approval of the hae treatment icatibant. with novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
Organization
Pharvaris Nv
Employees
83
CEO
Mr. Berndt Axel Edvard Modig CPA, M.B.A.
Industry
Services

Management People of Pharvaris Nv

NameTitle
Mr. Berndt Axel Edvard Modig CPA, M.B.A.
Co-Founder, CEO & Executive Director
Ms. Anna Nijdam M.Sc., R.A.
Head of Strategic Finance & Principal Accounting Officer
Dr. Stefan Abele Ph.D.
Chief Technology Operations Officer
Ms. Annick Deschoolmeester
Chief Human Resources Officer
Dr. Peng Lu M.D., Ph.D.
Chief Medical Officer
Dr. Anne A. Lesage Ph.D.
Chief Early Development Officer
Mr. Wim Souverijns Ph.D.
Chief Commercial Officer
Mr. David W. Nassif J.D.
CFO & Corporate Secretary
Maryann Cimino
Director of Corporate Relations

Important FAQs about investing in Pharvaris Nv from India :

What is Pharvaris Nv share price today?

Pharvaris Nv share price today stands at $18.06, Open: $18.30 ; Previous Close: $18.53 ; High: $18.60 ; Low: $18.05 ; 52 Week High: $33.00 ; 52 Week Low: $15.37. The stock opens at $18.30, after a previous close of $18.53. The stock reached a daily high of $18.60 and a low of $18.05, with a 52-week high of $33.00 and a 52-week low of $15.37.

Can Indians buy Pharvaris Nv shares?

Yes, Indians can invest in the Pharvaris Nv (PHVS) from India.

With INDmoney, you can buy Pharvaris Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pharvaris Nv at zero transaction cost.

How can I buy Pharvaris Nv shares from India?

It is very easy to buy Pharvaris Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pharvaris Nv be purchased?

Yes, you can buy fractional shares of Pharvaris Nv with INDmoney app.

What are the documents required to start investing in Pharvaris Nv stocks?

To start investing in Pharvaris Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pharvaris Nv

Today’s highest price of Pharvaris Nv (PHVS) is $18.60.

Today’s lowest price of Pharvaris Nv (PHVS) is $18.05.

What is today's market capitalisation of Pharvaris Nv

Today's market capitalisation of Pharvaris Nv PHVS is 1.0B

What is the 52 Week High and Low Range of Pharvaris Nv

  • 52 Week High

    $33.00

  • 52 Week Low

    $15.37

What are the historical returns of Pharvaris Nv?

  • 1 Month Returns

    -0.05%

  • 3 Months Returns

    6.8%

  • 1 Year Returns

    -28.76%

  • 5 Years Returns

    -36.1%

Who is the Chief Executive Officer (CEO) of Pharvaris Nv

Mr. Berndt Axel Edvard Modig CPA, M.B.A. is the current Chief Executive Officer (CEO) of Pharvaris Nv.